Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Biotechnology
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(5027)
•••
nozzpack
X
Post by
nozzpack
on Nov 11, 2021 5:50pm
Q3 Steady as she goes
Cipher earns $796,000 (U.S.) from continuing ops in Q3 2021-11-11 17:11 ET - News Release Mr. Craig Mull reports CIPHER ANNOUNCES THIRD QUARTER AND YEAR-TO-DATE 2021
...more
(106)
•••
Northforce13
X
Post by
Northforce13
on Nov 11, 2021 5:48pm
Disappointing Q3
Wasn't horrible, but was hoping for much better. Negative is the falloff in licensing revenue, larger than I would have expected, in the U.S. Somewhat positive is the continued high YOY growth
...more
(0)
•••
Rsoleblocka
X
Comment by
Rsoleblocka
on Nov 10, 2021 3:51pm
RE:RE:RE:Buying today
Part of my reason for selling some is that I am retiring in the next 2 years and had a big chunk of CPH in my holdings of TSFA so knocking it back a bit. I do believe in the company as an investment
...more
(0)
•••
Rsoleblocka
X
Comment by
Rsoleblocka
on Nov 10, 2021 3:42pm
RE:RE:Buying today
Thanks for the great posts, truly appreciated. I decided to sell some and hold some for the future. Best of luck to all my fellow longs!
(106)
•••
Northforce13
X
Comment by
Northforce13
on Nov 10, 2021 3:39pm
RE:Buying today
This thing could go to the moon People selling haven't done deep enough research to be confident in it, and are selling out of fear that it might decline and that they would not have crystallized
...more
(1)
•••
GJS471
X
Post by
GJS471
on Nov 10, 2021 2:22pm
Buying today
I have been buying, not selling. I have owned the company for a long time and I believe much of the past baggage (both financially and managerially) is gone. The numbers last quarter were
...more
(271)
•••
microcaphobby
X
Comment by
microcaphobby
on Nov 10, 2021 1:27pm
RE:earnings
I sold most of mine today and yesterday.
(0)
•••
Rsoleblocka
X
Post by
Rsoleblocka
on Nov 09, 2021 11:00pm
earnings
any thoughts on the board regarding this set of earnings? i realize it is all speculation but i am contemplating selling my shares tomorrow to limit the risk of an earnings disappointment. For some
...more
(5027)
•••
nozzpack
X
Comment by
nozzpack
on Nov 07, 2021 5:44pm
RE:Investors flock to Sun Pharma
The three Absorica versions combined are holding their own market share at about 7 %. LD is increasing , original Absorica is declining and the generic is coming up the middle . Q3 is modestly
...more
(5027)
•••
nozzpack
X
Post by
nozzpack
on Nov 06, 2021 7:20am
Investors flock to Sun Pharma
Strong growth in the US including Absorica LD.. https://www.livemint.com/market/mark-to-market/investors-flock-to-sun-pharma-on-strong-q1-lack-of-negative-surprises-11627840915551.html
(5027)
•••
nozzpack
X
Post by
nozzpack
on Nov 05, 2021 6:03pm
Q3 on Nov 11
Looking forward to it after several months of no news..
(5027)
•••
nozzpack
X
Post by
nozzpack
on Oct 18, 2021 7:50am
Bought Back and Cancelled 116,300 shares in September
Eom
(5027)
•••
nozzpack
X
Post by
nozzpack
on Oct 15, 2021 9:18am
Fair Value of $14 per share at Peer EV/ Ebitda
Current EV/Ebitda multiple is 17.22 times..see link below All Values in C $. EV = Market cap plius debt less cash =$51 million. Annual Ebitda - Q2 X 4 X 1.25 = $4.1 US X 4 x 1.25 = $20.5 in C
...more
(5027)
•••
nozzpack
X
Comment by
nozzpack
on Oct 14, 2021 8:31pm
RE:MOB-015
Thank you . Every man has his price . It was always my impression that Mull was setting up Cipher to be a cash cow, which would place us right in the sweet spot for potential acquirers. GUD looks
...more
(106)
•••
Northforce13
X
Post by
Northforce13
on Oct 11, 2021 9:59pm
MOB-015
I should have probably mentioned in my prior post that MOB-015 will hit the market in 2023/2024 and revenues will only start to occur at that point. So the valuation jump to CPH from that is
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Freegold Achieves over 90% Gold Recovery Using BIOX® and greater than 92% Gold Recovery using POX
Gold rush 2025: Why Desert Gold Ventures Inc. is now on the brink of a historic revaluation!
Eminent Continues to Hit Gold Mineralization at its Hot Springs Range Project in Nevada
Maiden Resource Estimate of 54 Moz at 284 gpt Silver, Highlights High-Grade Potential at Columba